Champions Oncology, Inc.
CSBR · NASDAQ
10/31/2025 | 7/31/2025 | 4/30/2025 | 1/31/2025 | |
|---|---|---|---|---|
| Market Cap | $0 | $0 | $0 | $0 |
| - Cash | $0 | $0 | $0 | $0 |
| + Debt | $0 | $0 | $0 | $0 |
| Enterprise Value | $0 | $0 | $0 | $0 |
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | 7.4% | 13.3% | -27.5% | – |
| Gross Profit | $0 | $0 | $0 | $0 |
| % Margin | 49.3% | 40.3% | 38% | 58.8% |
| EBITDA | $0 | -$0 | -$0 | $0 |
| % Margin | 4.1% | -0.7% | -12.7% | 28.9% |
| Net Income | $0 | -$0 | -$0 | $0 |
| % Margin | 2% | -3.1% | -14.8% | 26.4% |
| EPS Diluted | 0.019 | -0.032 | -0.13 | 0.31 |
| % Growth | 158.5% | 75.7% | -141.9% | – |
| Operating Cash Flow | -$0 | $0 | $0 | $0 |
| Capital Expenditures | -$0 | -$0 | -$0 | -$0 |
| Free Cash Flow | -$0 | $0 | $0 | $0 |